共 40 条
Anaphylaxis
被引:113
作者:
Estelle, F.
[1
,2
]
Simons, R.
[1
,2
]
机构:
[1] Univ Manitoba, Allergy & Clin Immunol Sect, Dept Pediat & Child Hlth, Dept Immunol, Winnipeg, MB R3T 2N2, Canada
[2] Univ Manitoba, Canadian Inst Hlth Res, Natl Training Program Allergy & Asthma, Fac Med, Winnipeg, MB R3T 2N2, Canada
关键词:
anaphylaxis;
allergic reaction;
mast cell;
basophil;
IgE;
Fc epsilon RI;
histamine;
tryptase;
food allergy;
venom allergy;
medication allergy;
epinephrine;
adrenaline;
H-1-antihistamine;
D O I:
10.1016/j.jaci.2007.08.061
中图分类号:
R392 [医学免疫学];
学科分类号:
100102 ;
摘要:
Anaphylaxis is an acute-onset, potentially fatal systemic allergic reaction. It is usually triggered by an agent such as an insect sting, food, or medication, through a mechanism involving IgE and the high-affinity IgE receptor on mast cells or basophils. Less commonly, it is triggered through other immunologic mechanisms, or through nonimmunologic mechanisms. It often occurs in community settings. Anaphylaxis episodes range in severity from those that are mild and resolve spontaneously to those that are fatal within minutes. The clinical diagnosis is based on a meticulous history and physical examination, sometimes, but not necessarily, supported by a laboratory test such as an elevated serum total tryptase level. Sensitization to allergen triggers suggested by the history needs to be confirmed by skin testing and measurement of allergen-specific IgE. In some sensitized individuals, additional tests are needed to assess the risk of future anaphylaxis episodes. Prompt injection of epinephrine is life-saving. H-1-antihistamines and inhaled beta(2)-adrenergic agonists cannot be depended on to prevent fatality. Long-term risk reduction is an integral part of management.
引用
收藏
页码:S402 / S407
页数:6
相关论文